BAD HOMBURG (dpa-AFX) – After only two months, the ailing dialysis group Fresenius Medical Care (FMC (Fresenius Medical Care)) is making the next change at the top of the company. Carla Kriwet resigned from her position as chairwoman and member of the Management Board with effect from December 5, 2022, the subsidiary of the Fresenius medical group (Fresenius SECo) announced late Monday evening. Effective December 6, Helen Giza will take over the management of the company. She will also remain CFO – she took over the role in 2019 – until a successor is found.
Michael Sen, who took over the Fresenus management of the company in early October, which had been in crisis for some time under his predecessor Stephan Sturm, said according to the announcement: “In a fundamentally healthy industry, Fresenius Medical Care must focus even more on the operational turnaround.” Helen Giza “gained in-depth expertise in the field of kidney disease and a thorough understanding of the company during her time at Fresenius Medical Care.”
FMC have been struggling with nursing staff shortages in the US, supply chain issues, and rising wages and material costs for some time. The impact of improvement measures in healthcare services in North America was delayed because of the difficult environment, it was said in October. Therefore, shortly after taking office, she had to lower the earnings outlook for 2022.
Sen has made it his mission to realign Fresenius and thus lead it out of the crisis. He is a proven financial expert, well respected by investors
/mis
Leverage must be between 2 and 20
No data